|Bid||4.8300 x 0|
|Ask||4.8400 x 0|
|Day's range||4.7900 - 4.9500|
|52-week range||4.7550 - 20.0800|
|Beta (5Y monthly)||1.44|
|PE ratio (TTM)||N/A|
|Earnings date||24 Feb 2022 - 28 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||8.11|
Despite the dip last year, the marijuana industry consists of excellent growth stocks that have the potential to flourish in the coming years. The U.S. cannabis companies, in particular, saw drastic revenue growth amid the ongoing pandemic. The ramp-up of state legalization also gave a boost to marijuana sales.
The company delayed the release of an SEC filing and got dragged down by the broad downturn in cannabis stocks.
Here is how CoDiagnostics, Inc. (CODX) and Cronos Group (CRON) have performed compared to their sector so far this year.